Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness.

Morin A. Self-awareness part 1: Definition, measures, effects, functions, and antecedents. Soc Personal Psychol Compass. 2011;5(10):807–23. https://doi.org/10.1111/j.1751-9004.2011.00387.x .

doi: 10.1111/j.1751-9004.2011.00387.x

Mograbi DC, Huntley J, Critchley H. Self-awareness in dementia: A taxonomy of processes, overview of findings, and integrative framework. Curr Neurol Neurosci Rep. 2021;21(12):69. https://doi.org/10.1007/s11910-021-01155-6 .

doi: 10.1007/s11910-021-01155-6 pubmed: 34817738 pmcid: 8613100

Mograbi DC, Hall S, Arantes B, Huntley J. The cognitive neuroscience of self-awareness: Current framework, clinical implications, and future research directions. Wiley Interdiscipl Rev: Cogn Sci. 2023:e1670. https://doi.org/10.1002/wcs.1670 .

Lou HC, Changeux JP, Rosenstand A. Towards a cognitive neuroscience of self-awareness. Neurosci & Biobehav Rev. 2017;83:765–73. https://doi.org/10.1016/j.neubiorev.2016.04.004 .

doi: 10.1016/j.neubiorev.2016.04.004

Quadt L, Critchley HD, Garfinkel SN. The neurobiology of interoception in health and disease. Ann N Y Acad Sci. 2018;1428(1):112–28. https://doi.org/10.1111/nyas.13915 .

doi: 10.1111/nyas.13915 pubmed: 29974959

Tsakiris M, Longo MR, Haggard P. Having a body versus moving your body: neural signatures of agency and body-ownership. Neuropsychologia. 2010;48(9):2740–9. https://doi.org/10.1016/j.neuropsychologia.2010.05.021 .

doi: 10.1016/j.neuropsychologia.2010.05.021 pubmed: 20510255

Fleming SM, Dolan RJ. The neural basis of metacognitive ability. Philos Trans Royal Soc B: Biol Sci. 2012;367(1594):1338–49. https://doi.org/10.1098/rstb.2011.0417 .

doi: 10.1098/rstb.2011.0417

Preller KH, Vollenweider FX. Phenomenology, structure, and dynamic of psychedelic states. Behav Neurobiol Psychedelic Drugs. 2018:221–56. https://doi.org/10.1007/7854_2016_459 .

Yaden DB, Johnson MW, Griffiths RR, Doss MK, Garcia-Romeu A, Nayak S, et al. Psychedelics and consciousness: Distinctions, demarcations, and opportunities. Int J Neuropsychopharmacol. 2021;24(8):615–23. https://doi.org/10.1093/ijnp/pyab026 .

doi: 10.1093/ijnp/pyab026 pubmed: 33987652 pmcid: 8378075

Wallach J, Cao AB, Calkins MM, Heim AJ, Lanham JK, Bonniwell EM, et al. Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential. Nat Commun. 2023;14(1):8221. https://doi.org/10.1038/s41467-023-44016-1 .

doi: 10.1038/s41467-023-44016-1 pubmed: 38102107 pmcid: 10724237

Nichols DE, Walter H. The history of psychedelics in psychiatry. Pharmacopsychiatry. 2020;54(04):151–66. https://doi.org/10.1055/a-1310-3990 .

doi: 10.1055/a-1310-3990 pubmed: 33285579

Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, et al. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med. 2019;49(4):655–63. https://doi.org/10.1017/S0033291718001356 .

doi: 10.1017/S0033291718001356 pubmed: 29903051 pmcid: 6378413

Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J. Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. Psychopharmacology. 2021;238:341–54. https://doi.org/10.1007/s00213-020-05719-1 .

doi: 10.1007/s00213-020-05719-1 pubmed: 33427944 pmcid: 7826317

Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, et al. Trial of psilocybin versus escitalopram for depression. N Engl J Med. 2021;384(15):1402–11. https://doi.org/10.1056/NEJMoa2032994 .

doi: 10.1056/NEJMoa2032994 pubmed: 33852780

Li NX, Hu YR, Chen WN, Zhang B. Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis. J Affect Disord. 2022;296:26–34. https://doi.org/10.1016/j.jad.2021.09.041 .

doi: 10.1016/j.jad.2021.09.041 pubmed: 34587546

Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, Brenneisen R. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis. 2014;202(7):513. https://doi.org/10.1097/NMD.0000000000000113 .

doi: 10.1097/NMD.0000000000000113 pubmed: 24594678 pmcid: 4086777

Feduccia AA, Jerome L, Klosinski B, Emerson A, Mithoefer MC, Doblin R. Breakthrough for trauma treatment: safety and efficacy of MDMA-assisted psychotherapy compared to paroxetine and sertraline. Front Psych. 2019;10:481147. https://doi.org/10.3389/fpsyt.2019.00650 .

doi: 10.3389/fpsyt.2019.00650

Smith KW, Sicignano DJ, Hernandez AV, White CM. MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review with meta-analysis. J Clin Pharmacol. 2022;62(4):463–71. https://doi.org/10.1002/jcph.1995 .

doi: 10.1002/jcph.1995 pubmed: 34708874

Schenberg EE. Psychedelic-assisted psychotherapy: a paradigm shift in psychiatric research and development. Front Pharmacol. 2018;9:733. https://doi.org/10.3389/fphar.2018.00733 .

doi: 10.3389/fphar.2018.00733 pubmed: 30026698 pmcid: 6041963

Mayer-Gross W, Stein H. Über einige abänderungen der sinnestätigkeit im Meskalinrausch. Zeitschrift für die gesamte Neurol Psychiatr. 1926;101(1):354–86. https://doi.org/10.1007/BF02878343 .

doi: 10.1007/BF02878343

Beringer K. Der Meskalinrausch. Berlin: Springer; 1927.

doi: 10.1007/978-3-662-11451-3

Huxley A. The Doors of Perception. New York: Harper & Row; 1954.

Hayes SC, Law S, Malady M, Zhu Z, Bai X. The centrality of sense of self in psychological flexibility processes: What the neurobiological and psychological correlates of psychedelics suggest. J Contextual Behav Sci. 2020;15:30–8. https://doi.org/10.1016/j.jcbs.2019.11.005 .

doi: 10.1016/j.jcbs.2019.11.005

Bienemann B, Ruschel NS, Campos ML, Negreiros MA, Mograbi DC. Self-reported negative outcomes of psilocybin users: A quantitative textual analysis. PLoS One. 2020;15(2):e0229067. https://doi.org/10.1371/journal.pone.0229067 .

doi: 10.1371/journal.pone.0229067 pubmed: 32084160 pmcid: 7034876

Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin. Hum Brain Mapp. 2015;36(8):3137–53. https://doi.org/10.1002/hbm.22833 .

doi: 10.1002/hbm.22833 pubmed: 26010878 pmcid: 6869189

Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology. 2011;218(4):649–65. https://doi.org/10.1007/s00213-011-2358-5 .

doi: 10.1007/s00213-011-2358-5 pubmed: 21674151 pmcid: 3308357

Dennett D. In: Kessel F, Cole P, Johnson D, editors. Self and consciousness: multiple perspectives. Hillsdale: Erlbaum; 1992.

Northoff G, Bermpohl F. Cortical midline structures and the self. Trends Cogn Sci. 2004;8(3):102–7. https://doi.org/10.1016/j.tics.2004.01.004 .

doi: 10.1016/j.tics.2004.01.004 pubmed: 15301749

Northoff G, Heinzel A, De Greck M, Bermpohl F, Dobrowolny H, Panksepp J. Self-referential processing in our brain—a meta-analysis of imaging studies on the self. Neuroimage. 2006;31(1):440–57. https://doi.org/10.1016/j.neuroimage.2005.12.002 .

doi: 10.1016/j.neuroimage.2005.12.002 pubmed: 16466680

Snyder AZ, Raichle ME. A brief history of the resting state: the Washington University perspective. Neuroimage. 2012;62(2):902–10. https://doi.org/10.1016/j.neuroimage.2012.01.044 .

doi: 10.1016/j.neuroimage.2012.01.044 pubmed: 22266172

Callard F, Margulies DS. What we talk about when we talk about the default mode network. Front Hum Neurosci. 2014;8:619. https://doi.org/10.3389/fnhum.2014.00619 .

doi: 10.3389/fnhum.2014.00619 pubmed: 25202250 pmcid: 4142807

Mittner M, Hawkins GE, Boekel W, Forstmann BU. A neural model of mind wandering. Trends Cogn Sci. 2016;20(8):570–8. https://doi.org/10.1016/j.tics.2016.06.004 .

doi: 10.1016/j.tics.2016.06.004 pubmed: 27353574

Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci USA. 2003;100:253–8. https://doi.org/10.1073/pnas.0135058100 .

doi: 10.1073/pnas.0135058100 pubmed: 12506194

Shulman GL, Fiez JA, Corbetta M, Buckner RL, Miezin FM, Raichle ME, Petersen SE. Common blood flow changes across visual tasks: II. Decreases Cerebral Cortex J Cogn Neurosci. 1997;9:648–63. https://doi.org/10.1162/jocn.1997.9.5.648 .

doi: 10.1162/jocn.1997.9.5.648 pubmed: 23965122

Davey CG, Pujol J, Harrison BJ. Mapping the self in the brain’s default mode network. Neuroimage. 2016;132:390–7. https://doi.org/10.1016/j.neuroimage.2016.02.022 .

doi: 10.1016/j.neuroimage.2016.02.022 pubmed: 26892855

Whitfield-Gabrieli S, Moran JM, Nieto-Castañón A, Triantafyllou C, Saxe R, Gabrieli JD. Associations and dissociations between default and self-reference networks in the human brain. Neuroimage. 2011;55:225–32. https://doi.org/10.1016/j.neuroimage.2010.11.048 .

doi: 10.1016/j.neuroimage.2010.11.048 pubmed: 21111832

Vanhaudenhuyse A, Noirhomme Q, Tshibanda LJF, Bruno MA, Boveroux P, Schnakers C, et al. Default network connectivity reflects the level of consciousness in non-communicative brain-damaged patients. Brain. 2010;133(1):161–71. https://doi.org/10.1093/brain/awp313 .

doi: 10.1093/brain/awp313 pubmed: 20034928

Hannawi Y, Lindquist MA, Caffo BS, Sair HI, Stevens RD. Resting brain activity in disorders of consciousness: a systematic review and meta-analysis. Neurology. 2015;84(12):1272–80. https://doi.org/10.1016/j.jcbs.2019.11.005 .

doi: 10.1016/j.jcbs.2019.11.005 pubmed: 25713001 pmcid: 4366089

Zhao W, Yao S, Li Q, Geng Y, Ma X, Luo L, et al. Oxytocin blurs the self-other distinction during trait judgments and reduces medial prefrontal cortex responses. Hum Brain Mapp. 2016;37(7):2512–27. https://doi.org/10.1002/hbm.23190 .

doi: 10.1002/hbm.23190 pubmed: 27016006 pmcid: 6867482

Delahoy R, Davey CG, Jamieson AJ, Finlayson-Short L, Savage HS, Steward T, Harrison BJ. Modulation of the brain’s core-self network by self-appraisal processes. NeuroImage. 2022;251:118980. https://doi.org/10.1016/j.neuroimage.2022.118980 .

doi: 10.1016/j.neuroimage.2022.118980 pubmed: 35143976

Binder JR, Desai RH. The neurobiology of semantic memory. Trends Cogn Sci. 2011;15:527–36. https://doi.org/10.1016/j.tics.2011.10.001 .

doi: 10.1016/j.tics.2011.10.001 pubmed: 22001867 pmcid: 3350748

Kwon S, Richter FR, Siena MJ, Simons JS. Episodic memory precision and reality monitoring following stimulation of angular gyrus. J Cogn Neurosci. 2022;34:687–98.

pubmed: 35015889 doi: 10.1162/jocn_a_01814

Summerfield JJ, Hassabis D, Maguire EA. Cortical midline involvement in autobiographical memory. Neuroimage. 2009;44(3):1188–200. https://doi.org/10.1016/j.neuroimage.2008.09.033 .

doi: 10.1016/j.neuroimage.2008.09.033 pubmed: 18973817

Stoliker D, Egan GF, Friston KJ, Razi A. Neural mechanisms and psychology of psychedelic ego dissolution. Pharmacol Rev. 2022;74(4):876–917. https://doi.org/10.1124/pharmrev.121.000508 .

doi: 10.1124/pharmrev.121.000508 pubmed: 36786290

McCutcheon RA, Nour MM, Dahoun T, Jauhar S, Pepper F, Expert P, et al. Mesolimbic dopamine function is related to salience network connectivity: an integrative positron emission tomography and magnetic resonance study. Biol Psychiatry. 2019;85(5):368–78. https://doi.org/10.1016/j.biopsych.2018.09.010 .

doi: 10.1016/j.biopsych.2018.09.010 pubmed: 30389131 pmcid: 6360933

Sridharan D, Levitin DJ, Menon V. A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks. Proc Natl Acad Sci. 2008;105(34):12569–74. https://doi.org/10.1073/pnas.0800005105 .

doi: 10.1073/pnas.0800005105 pubmed: 18723676 pmcid: 2527952

McTeague LM, Huemer J, Carreon DM, Jiang Y, Eickhoff SB, Etkin A. Identification of common neural circuit disruptions in cognitive control across psychiatric disorders. Am J Psychiatry. 2017;174(7):676–85. https://doi.org/10.1176/appi.ajp.2017.16040400 .

doi: 10.1176/appi.ajp.2017.16040400 pubmed: 28320224 pmcid: 5543416

Critchley HD, Garfinkel SN. Interoception and emotion. Curr Opin Psychol. 2017;17:7–14. https://doi.org/10.1016/j.copsyc.2017.04.020 .

doi: 10.1016/j.copsyc.2017.04.020 pubmed: 28950976

Balthazar ML, Pereira FR, Lopes TM, da Silva EL, Coan AC, Campos BM, et al. Neuropsychiatric symptoms in Alzheimer's disease are related to functional connectivity alterations in the salience network. Hum Brain Mapp. 2014;35(4):1237–46. https://doi.org/10.1002/hbm.22248 .

doi: 10.1002/hbm.22248 pubmed: 23418130

Palaniyappan L, White TP, Liddle PF. The concept of salience network dysfunction in schizophrenia: from neuroimaging observations to therapeutic opportunities. Curr Top Med Chem. 2012;12(21):2324–38. https://doi.org/10.2174/156802612805289881 .

doi: 10.2174/156802612805289881 pubmed: 23279173

Bomilcar I, Bertrand E, Morris RG, Mograbi DC. The seven selves of dementia. Front Psych. 2021;12:646050. https://doi.org/10.3389/fpsyt.2021.646050 .

doi: 10.3389/fpsyt.2021.646050

Nelson B, Fornito A, Harrison BJ, Yücel M, Sass LA, Yung AR, et al. A disturbed sense of self in the psychosis prodrome: linking phenomenology and neurobiology. Neurosci Biobehav Rev. 2009;33(6):807–17. https://doi.org/10.1016/j.neubiorev.2009.01.002 .

doi: 10.1016/j.neubiorev.2009.01.002 pubmed: 19428493

Alves PN, Foulon C, Karolis V, Bzdok D, Margulies DS, Volle E, Thiebaut de Schotten M. An improved neuroanatomical model of the default-mode network reconciles previous neuroimaging and neuropathological findings. Commun Biol. 2019;2(1):370. https://doi.org/10.1038/s42003-019-0611-3 .

doi: 10.1038/s42003-019-0611-3 pubmed: 31633061 pmcid: 6787009

Møller A, Rømer Thomsen K, Brooks DJ, Mouridsen K, Blicher JU, Hansen KV, Lou HC. Attenuation of dopamine-induced GABA release in problem gamblers. Brain Behav. 2019;9(3):e01239.

pubmed: 30788911 pmcid: 6422713 doi: 10.1002/brb3.1239

Mantini D, Perrucci MG, Del Gratta C, Romani GL, Corbetta M. Electrophysiological signatures of resting state networks in the human brain. Proc Natl Acad Sci USA. 2007;104:13170–5. https://doi.org/10.1073/pnas.0700668104 .

doi: 10.1073/pnas.0700668104 pubmed: 17670949 pmcid: 1941820

Berkovich-Ohana A, Glicksohn J, Goldstein A. Mindfulness-induced changes in gamma band activity - implications for the default mode network, self-reference and attention. Clin Neurophysiol. 2012;123:700–10. https://doi.org/10.1016/j.clinph.2011.07.048 .

doi: 10.1016/j.clinph.2011.07.048 pubmed: 21940201

Nir Y, Fisch L, Mukamel R, Gelbard-Sagiv H, Arieli A, Fried I, et al. Coupling between neuronal firing rate, gamma LFP, and BOLD fMRI is related to interneuronal correlations. Curr Biol. 2007;17:1275–85. https://doi.org/10.1016/j.cub.2007.06.066 .

doi: 10.1016/j.cub.2007.06.066 pubmed: 17686438

Jerbi K, Vidal JR, Ossandón T, Dalal SS, Jung J, Hoffmann D, et al. Exploring the electrophysiological correlates of the default-mode network with intracerebral EEG. Front Syst Neurosci. 2010;4:27. https://doi.org/10.3389/fnsys.2010.00027 .

doi: 10.3389/fnsys.2010.00027 pubmed: 20661461 pmcid: 2907269

Ossandón T, Jerbi K, Vidal JR, Bayle DJ, Henaff MA, Jung J, et al. Transient suppression of broadband gamma power in the default-mode network is correlated with task complexity and subject performance. J Neurosci. 2011;31:14521–30. https://doi.org/10.1523/JNEUROSCI.2483-11.2011 .

doi: 10.1523/JNEUROSCI.2483-11.2011 pubmed: 21994368 pmcid: 6703400

Ramot M, Fisch L, Harel M, Kipervasser S, Andelman F, Neufeld MY, et al. A widely distributed spectral signature of task-negative electrocorticography responses revealed during a visuomotor task in the human cortex. J Neurosci. 2012;32:10458–69. https://doi.org/10.1523/JNEUROSCI.0877-12.2012 .

doi: 10.1523/JNEUROSCI.0877-12.2012 pubmed: 22855795 pmcid: 6621389

Fuentemilla L, Palombo DJ, Levine B. Gamma phase-synchrony in autobiographical memory: Evidence from magnetoencephalography and severely deficient autobiographical memory. Neuropsychologia. 2018;110:7–13. https://doi.org/10.1016/j.neuropsychologia.2017.08.020 .

doi: 10.1016/j.neuropsychologia.2017.08.020 pubmed: 28822732

Schnitzler A, Gross J. Normal and pathological oscillatory communication in the brain. Nat Rev Neurosci. 2005;6(4):285–96.

pubmed: 15803160 doi: 10.1038/nrn1650

Lou HC, Luber B, Crupain M, Keenan JP, Nowak M, Kjaer TW, et al. Parietal cortex and representation of the mental Self. Proc Natl Acad Sci. 2004;101(17):6827–32.

pubmed: 15096584 pmcid: 404216 doi: 10.1073/pnas.0400049101

Luber B, Lou HC, Keenan JP, Lisanby SH. Self-enhancement processing in the default network: A single-pulse TMS study. Exp Brain Res. 2012;223(2):177–87.

pubmed: 22965551 pmcid: 4055952 doi: 10.1007/s00221-012-3249-7

Lou HC, Rosenstand A, Brooks DJ, Bender D, Jakobsen S, Blicher JU, et al. Exogenous dopamine reduces GABA receptor availability in the human brain. Brain Behav. 2016;6(7):e00484.

pubmed: 27247854 pmcid: 4864053 doi: 10.1002/brb3.484

Rømer Thomsen K, Joensson M, Lou HC, Moller A, Gross J, Kringelbach ML, Changeux JP. Altered paralimbic interaction in behavioral addiction. Proc Natl Acad Sci. 2013;110(12):4744–9.

pubmed: 23487797 pmcid: 3606979 doi: 10.1073/pnas.1302374110

Hall SD, Barnes GR, Furlong PL, Seri S, Hillebrand A. Neuronal network pharmacodynamics of GABAergic modulation in the human cortex determined using pharmaco-magnetoencephalography. Hum Brain Mapp. 2010;31(4):581–94.

pubmed: 19937723 doi: 10.1002/hbm.20889

Stephens DN, King SL, Lambert JJ, Belelli D, Duka T. GABAA receptor subtype involvement in addictive behaviour. Genes Brain Behav. 2017;16(1):149–84.

pubmed: 27539865 doi: 10.1111/gbb.12321

Johnston GAR. Muscimol as an Ionotropic GABA Receptor Agonist. Neurochem Res. 2014;39:1942–7. https://doi.org/10.1007/s11064-014-1245-y .

doi: 10.1007/s11064-014-1245-y pubmed: 24473816

Keenan JP, Nelson A, O'Connor M, Pascual-Leone A. Self-recognition and the right hemisphere. Nature. 2001;409(6818):305–5.

pubmed: 11201730 doi: 10.1038/35053167

Joensson M, Thomsen KR, Andersen LM, Gross J, Mouridsen K, Sandberg K, et al. Making sense: dopamine activates conscious self-monitoring through medial prefrontal cortex. Hum Brain Mapp. 2015;36(5):1866–77. https://doi.org/10.1002/hbm.22742 .

doi: 10.1002/hbm.22742 pubmed: 25627861 pmcid: 4737196

Rosenstand AF, Rømer Thomsen K, Lou HC. Conscious self-monitoring: from molecule to culture. Cult Brain. 2022;10(Suppl 1):1–9.

doi: 10.1007/s40167-022-00108-1

Lou HC, Rømer Thomsen K, Changeux JP. The molecular organization of self-awareness: paralimbic dopamine-GABA interaction. Front Syst Neurosci. 2020;14:3.

pubmed: 32047425 pmcid: 6997345 doi: 10.3389/fnsys.2020.00003

Changeux JP, Lou HC. Emergent pharmacology of conscious experience: new perspectives in substance addiction. FASEB J. 2011;25(7):2098–108. https://doi.org/10.1096/fj.11-0702ufm .

doi: 10.1096/fj.11-0702ufm pubmed: 21719514

Juckel G. Serotonin: from sensory processing to schizophrenia using an electrophysiological method. Behav Brain Res. 2015;277:121–4. https://doi.org/10.1016/j.bbr.2014.05.042 .

doi: 10.1016/j.bbr.2014.05.042 pubmed: 24971690

Liu Y, Sheng F, Woodcock KA, Han S. Oxytocin effects on neural correlates of self-referential processing. Biol Psychol. 2013;94(2):380–7.

pubmed: 23965321 doi: 10.1016/j.biopsycho.2013.08.003

Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, et al. Broadband cortical desynchronization underlies the human psychedelic state. J Neurosci. 2013;33(38):15171–83.

pubmed: 24048847 pmcid: 6618409 doi: 10.1523/JNEUROSCI.2063-13.2013

Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science. 1997;275(5306):1593–9.

pubmed: 9054347 doi: 10.1126/science.275.5306.1593

Takahashi YK, Batchelor HM, Liu B, Khanna A, Morales M, Schoenbaum G. Dopamine neurons respond to errors in the prediction of sensory features of expected rewards. Neuron. 2017;95(6):1395–405. https://doi.org/10.1016/j.neuron.2017.08.025 .

doi: 10.1016/j.neuron.2017.08.025 pubmed: 28910622 pmcid: 5658021

Rössler J, Rössler W, Seifritz E, Unterrassner L, Wyss T, Haker H, Wotruba D. Dopamine-induced dysconnectivity between salience network and auditory cortex in subjects with psychotic-like experiences: a randomized double-blind placebo-controlled study. Schizophr Bull. 2020;46(3):732–40. https://doi.org/10.1093/schbul/sbz110 .

doi: 10.1093/schbul/sbz110 pubmed: 31751466

Seeley WW. The salience network: a neural system for perceiving and responding to homeostatic demands. J Neurosci. 2019;39(50):9878–82. https://doi.org/10.1523/JNEUROSCI.1138-17.2019 .

doi: 10.1523/JNEUROSCI.1138-17.2019 pubmed: 31676604 pmcid: 6978945

Chong JSX, Ng GJP, Lee SC, Zhou J. Salience network connectivity in the insula is associated with individual differences in interoceptive accuracy. Brain Struct Funct. 2017;222:1635–44. https://doi.org/10.1007/s00429-016-1297-7 .

doi: 10.1007/s00429-016-1297-7 pubmed: 27573028

Guu SF, Chao YP, Huang FY, Cheng YT, Ng HYH, Hsu CF, et al. Interoceptive awareness: MBSR training alters information processing of salience network. Front Behav Neurosci. 2023;17:1008086. https://doi.org/10.3389/fnbeh.2023.1008086 .

doi: 10.3389/fnbeh.2023.1008086 pubmed: 37025109 pmcid: 10070746

Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160(1):13–23. https://doi.org/10.1176/appi.ajp.160.1.13 .

doi: 10.1176/appi.ajp.160.1.13 pubmed: 12505794

Hietala J, Syvälahti E, Vuorio K, Räkköläinen V, Bergman J, Haaparanta M, et al. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet (London, England). 1995;346(8983):1130–1.

pubmed: 7475604 doi: 10.1016/S0140-6736(95)91801-9

Reith J, Benkelfat C, Sherwin A, Yasuhara Y, Kuwabara H, Andermann F, et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc Natl Acad Sci. 1994;91(24):11651–4.

pubmed: 7972118 pmcid: 45289 doi: 10.1073/pnas.91.24.11651

Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci. 1997;94(6):2569–74. https://doi.org/10.1073/pnas.94.6.2569 .

doi: 10.1073/pnas.94.6.2569 pubmed: 9122236 pmcid: 20129

Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatr. 1998;155(6):761–7. https://doi.org/10.1176/ajp.155.6.761 .

doi: 10.1176/ajp.155.6.761 pubmed: 9619147

Gjedde A, Wong DF. Quantification of neuroreceptors in living human brain. V Endogenous neurotransmitter inhibition of haloperidol binding in psychosis. J Cerebral Blood Flow Metab. 2001;21(8):982–94.

doi: 10.1097/00004647-200108000-00011

Ginovart N, Kapur S. Role of dopamine D 2 receptors for antipsychotic activity. Curr Antipsychotics. 2012:27–52. https://doi.org/10.1007/978-3-642-25761-2_2 .

Huang H, Chen C, Rong B, Wan Q, Chen J, Liu Z, et al. Resting-state functional connectivity of salience network in schizophrenia and depression. Sci Rep. 2022;12(1):11204. https://doi.org/10.1038/s41598-022-15489-9 .

doi: 10.1038/s41598-022-15489-9 pubmed: 35778603 pmcid: 9249853

Zhou J, Greicius MD, Gennatas ED, Growdon ME, Jang JY, Rabinovici GD, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease. Brain. 2010;133(5):1352–67. https://doi.org/10.1093/brain/awq075 .

doi: 10.1093/brain/awq075 pubmed: 20410145 pmcid: 2912696

Conio B, Martino M, Magioncalda P, Escelsior A, Inglese M, Amore M, Northoff G. Opposite effects of dopamine and serotonin on resting-state networks: review and implications for psychiatric disorders. Mol Psychiatr. 2020;25(1):82–93. https://doi.org/10.1038/s41380-019-0406-4 .

doi: 10.1038/s41380-019-0406-4

Bar KJ, de la Cruz F, Schumann A, Koehler S, Sauer H, Critchley H, et al. Functional connectivity and network analysis of midbrain and brainstem nuclei. Neuroimage. 2016;134:53–63. https://doi.org/10.1016/j.neuroimage.2016.03.071 .

doi: 10.1016/j.neuroimage.2016.03.071 pubmed: 27046112

Haber SN, Fudge JL, McFarland NR. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci. 2000;20(23):69–82. https://doi.org/10.1523/JNEUROSCI.20-06-02369.2000 .

doi: 10.1523/JNEUROSCI.20-06-02369.2000

Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev. 1992;72(1):165–229. https://doi.org/10.1152/physrev.1992.72.1.165 .

doi: 10.1152/physrev.1992.72.1.165 pubmed: 1731370

Buzsaki G, Draguhn A. Neuronal oscillations in cortical networks. Science. 2004;304(5679):1926–9. https://doi.org/10.1126/science.1099745 .

doi: 10.1126/science.1099745 pubmed: 15218136

Lu H, Stein EA. Resting state functional connectivity: its physiological basis and application in neuropharmacology. Neuropharmacology. 2014;84:79–89. https://doi.org/10.1016/j.neuropharm.2013.08.023 .

doi: 10.1016/j.neuropharm.2013.08.023 pubmed: 24012656

Bentivoglio M, Morelli M. Chapter I The organization and circuits of mesencephalic dopaminergic neurons and the distribution of dopamine receptors in the brain. In: Handbook of chemical neuroanatomy, vol. 21. Elsevier; 2005. p. 1–107. https://doi.org/10.1016/S0924-8196(05)80005-3 .

doi: 10.1016/S0924-8196(05)80005-3

Carr GV, Lucki I. The role of serotonin receptor subtypes in treating depression: a review of animal studies. Psychopharmacology. 2011;213:265–87. https://doi.org/10.1007/s00213-010-2097-z .

doi: 10.1007/s00213-010-2097-z pubmed: 21107537

Bubic A, Von Cramon DY, Schubotz RI. Prediction, cognition and the brain. Front Hum Neurosci. 2010;4:1094. https://doi.org/10.3389/fnhum.2010.00025 .

doi: 10.3389/fnhum.2010.00025

Helmholtz H. Concerning the perceptions in general, Treatise on Physiological Optics, 3rded.: J. Southall Trans, III. New York: Dover; 1866/1962.

Gregory RL. Knowledge in perception and illusion. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 1997;352(1358):1121–7. https://doi.org/10.1098/rstb.1997.0095 .

doi: 10.1098/rstb.1997.0095 pmcid: 1692018

Dayan P, Hinton GE, Neal RM, Zemel RS. The helmholtz machine. Neural Comput. 1995;7(5):889–904. https://doi.org/10.1162/neco.1995.7.5.889 .

doi: 10.1162/neco.1995.7.5.889 pubmed: 7584891

Friston K. The free-energy principle: a unified brain theory? Nat Rev Neurosci. 2010;11(2):127–38. https://doi.org/10.1038/nrn2787 .

doi: 10.1038/nrn2787 pubmed: 20068583

Kannape OA, Blanke O. Agency, gait and self-consciousness. Int J Psychophysiol. 2012;83(2):191–9. https://doi.org/10.1016/j.ijpsycho.2011.12.006 .

doi: 10.1016/j.ijpsycho.2011.12.006 pubmed: 22226801

Deane G. Dissolving the self: Active inference, psychedelics, and ego-dissolution. Philos Mind Sci. 2020;1(I):1–27. https://doi.org/10.33735/phimisci.2020.I.39 .

doi: 10.33735/phimisci.2020.I.39

Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, et al. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci. 2012;109(6):2138–43. https://doi.org/10.1073/pnas.1119598109 .

doi: 10.1073/pnas.1119598109 pubmed: 22308440 pmcid: 3277566

Pasquini L, Palhano-Fontes F, Araujo DB. Subacute effects of the psychedelic ayahuasca on the salience and default mode networks. J Psychopharmacol. 2020;34(6):623–35.

pubmed: 32255395 doi: 10.1177/0269881120909409

Viol A, Palhano-Fontes F, Onias H, De Araujo DB, Viswanathan GM. Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca. Sci Rep. 2017;7(1):7388.

pubmed: 28785066 pmcid: 5547073 doi: 10.1038/s41598-017-06854-0

Tagliazucchi E, Carhart-Harris R, Leech R, Nutt D, Chialvo DR. Enhanced repertoire of brain dynamical states during the psychedelic experience. Hum Brain Mapp. 2014;35(11):5442–56. https://doi.org/10.1002/hbm.22562 .

doi: 10.1002/hbm.22562 pubmed: 24989126 pmcid: 6869695

Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, et al. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Human Neurosci. 2014;20 https://doi.org/10.3389/fnhum.2014.00020 .

Carhart-Harris RL, Friston KJ. REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacol Rev. 2019;71(3):316–44. https://doi.org/10.1124/pr.118.017160 .

doi: 10.1124/pr.118.017160 pubmed: 31221820 pmcid: 6588209

Preller KH, Razi A, Zeidman P, Stämpfli P, Friston KJ, Vollenweider FX. Effective connectivity changes in LSD-induced altered states of consciousness in humans. Proc Natl Acad Sci. 2019;116(7):2743–8.

pubmed: 30692255 pmcid: 6377471 doi: 10.1073/pnas.1815129116

Barrett FS, Doss MK, Sepeda ND, Pekar JJ, Griffiths RR. Emotions and brain function are altered up to one month after a single high dose of psilocybin. Sci Rep. 2020;10(1):2214. https://doi.org/10.1038/s41598-020-59282-y .

doi: 10.1038/s41598-020-59282-y pubmed: 32042038 pmcid: 7010702

Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, et al. Default mode network modulation by psychedelics: a systematic review. Int J Neuropsychopharmacol. 2023;26(3):155–88.

pubmed: 36272145 doi: 10.1093/ijnp/pyac074

Lage CA, Wolmarans DW, Mograbi DC. An evolutionary view of self-awareness. Behav Process. 2022;194:104543. https://doi.org/10.1016/j.beproc.2021.104543 .

doi: 10.1016/j.beproc.2021.104543

Bienemann B, Barbosa AR, Cruz LVMD, Multedo M, Mograbi D. Health benefits and positive acute effects of psilocybin consumption: A quantitative textual analysis of user self-reported data. J Psychoact Drugs. 2023:1–9.

Nour MM, Evans L, Nutt D, Carhart-Harris RL. Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI). Front Hum Neurosci. 2016;10:269.

pubmed: 27378878 pmcid: 4906025 doi: 10.3389/fnhum.2016.00269

Seth AK. Interoceptive inference, emotion, and the embodied self. Trends Cogn Sci. 2013;17(11):565–73. https://doi.org/10.1016/j.tics.2013.09.007 .

doi: 10.1016/j.tics.2013.09.007 pubmed: 24126130

Marschall J, Fejer G, Lempe P, Prochazkova L, Kuchar M, Hajkova K, van Elk M. Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study. J Psychopharmacol. 2022;36(1):97–113. https://doi.org/10.1177/02698811211050556 .

doi: 10.1177/02698811211050556 pubmed: 34915762

Cruz L, Bienemann B, Palhano-Fontes F, Tófoli LF, Araújo DB, Mograbi DC. A quantitative textual analysis of the subjective effects of ayahuasca in naïve users with and without depression. Sci Rep. 2023;13(1):19635. https://doi.org/10.1038/s41598-023-44193-5 .

doi: 10.1038/s41598-023-44193-5 pubmed: 37949934 pmcid: 10638373

Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, et al. Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans. Int J Neuropsychopharm. 2015;18(12):pyv065. https://doi.org/10.1093/ijnp/pyv065 .

doi: 10.1093/ijnp/pyv065

González D, Riba J, Bouso JC, Gómez-Jarabo G, Barbanoj MJ. Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend. 2006;85(2):157–62. https://doi.org/10.1016/j.drugalcdep.2006.04.001 .

doi: 10.1016/j.drugalcdep.2006.04.001 pubmed: 16720081

Millière R. Looking for the self: phenomenology, neurophysiology and philosophical significance of drug-induced ego dissolution. Front Hum Neurosci. 2017;11:245. https://doi.org/10.3389/fnhum.2017.00245 .

doi: 10.3389/fnhum.2017.00245 pubmed: 28588463 pmcid: 5441112

Dittrich A. Zusammenstellung eines Fragebogens (APZ) zur Erfassung abnormer psychischer Zustände [Construction of a questionnaire (APZ) for assessing abnormal mental states]. Z Klin Psychol Psychother. 1975;23:12–20.

Bodmer I, Dittrich A, Lamparter D. Aussergewöhnliche Bewusstseinszustände - Ihre gemeinsame Struktur und Messung [Altered states of consciousness - Their common structure and assessment]. In: Hofmann A, Leuner H, editors. Welten des Bewusstseins. Bd. 3. Berlin, Germany: VWB. Experimentelle Psychologie, Neurobiologie und Chemie; 1994. p. 45–58.

Dittrich, A., Lamparter, D., & Maurer, M. (2006). 5D-ABZ: Fragebogen zur Erfassung Aussergewöhnlicher Bewusstseinszustände. Zurich, Switzerland: PSIN PLUS. Eine kurze Einführung [5D-ASC: Questionnaire for the assessment of altered states of consciousness. A short introduction].

Dittrich A, Lamparter D, Maurer M. 5D-ASC: Questionnaire for the assessment of altered states of consciousness. A short introduction. Zurich, Switzerland: PSIN PLUS; 2010.

Wittmann M. Modulations of the experience of self and time. Conscious Cogn. 2015;38:172–81. https://doi.org/10.1016/j.concog.2015.06.008 .

doi: 10.1016/j.concog.2015.06.008 pubmed: 26121958

Duerler P, Brem S, Fraga-González G, Neef T, Allen M, Zeidman P, Stämpfli P, Vollenweider FX, Preller KH. Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study. Cerebral Cortex. 2021;32(1):186–96. https://doi.org/10.1093/cercor/bhab202 .

doi: 10.1093/cercor/bhab202 pubmed: 34255821

Watts R, Day C, Krzanowski J, Nutt D, Carhart-Harris R. Patients’ accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression. J Humanist Psychol. 2017;57(5):520–64. https://doi.org/10.1177/0022167817709585 .

doi: 10.1177/0022167817709585

Morgan HL, Turner DC, Corlett PR, Absalom AR, Adapa R, Arana FS, Pigott J, Gardner J, Everitt J, Haggard P, Fletcher PC. Exploring the impact of ketamine on the experience of illusory body ownership. Biol Psychiatry. 2011;69(1):35–41. https://doi.org/10.1016/j.biopsych.2010.07.032 .

doi: 10.1016/j.biopsych.2010.07.032 pubmed: 20947068 pmcid: 3025328

Tang J, Morgan HL, Liao Y, Corlett PR, Wang D, Li H, Tang Y, Chen J, Liu T, Hao W, Fletcher PC, Chen X. Chronic administration of ketamine mimics the perturbed sense of body ownership associated with schizophrenia. Psychopharmacology. 2015;232(9):1515–26. https://doi.org/10.1007/s00213-014-3782-0 .

doi: 10.1007/s00213-014-3782-0 pubmed: 25404087

Polito V, Stevenson RJ. A systematic study of microdosing psychedelics. PLoS One. 2019;14(2):e0211023. https://doi.org/10.1371/journal.pone.0211023 .

doi: 10.1371/journal.pone.0211023 pubmed: 30726251 pmcid: 6364961

Polito V, Barnier AJ, Woody EZ. Developing the Sense of Agency Rating Scale (SOARS): An empirical measure of agency disruption in hypnosis. Conscious Cogn. 2013;22(3):684–96. https://doi.org/10.1016/j.concog.2013.04.003 .

doi: 10.1016/j.concog.2013.04.003 pubmed: 23685619

Moore JW, Turner DC, Corlett PR, Arana FS, Morgan HL, Absalom AR, Adapa R, de Wit S, Everitt JC, Gardner JM, Pigott JS, Haggard P, Fletcher PC. Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia. Cogn Neuropsychiatry. 2011;16(4):364–81. https://doi.org/10.1080/13546805.2010.546074 .

doi: 10.1080/13546805.2010.546074 pubmed: 21302161 pmcid: 3144485

Moore JW, Cambridge VC, Morgan H, Giorlando F, Adapa R, Fletcher PC. Time, action and psychosis: using subjective time to investigate the effects of ketamine on sense of agency. Neuropsychologia. 2013;51(2):377–84. https://doi.org/10.1016/j.neuropsychologia.2012.07.005 .

doi: 10.1016/j.neuropsychologia.2012.07.005 pubmed: 22813429 pmcid: 3562439

Carruthers G. A metacognitive model of the sense of agency over thoughts. Cogn Neuropsychiatry. 2012;17(4):291–314. https://doi.org/10.1080/13546805.2011.627275 .

doi: 10.1080/13546805.2011.627275 pubmed: 22150422

Gerrans P. Delusional attitudes and default thinking. Mind Lang. 2013;28(1):83–102. https://doi.org/10.1111/mila.12010 .

doi: 10.1111/mila.12010

Palhano-Fontes F, Andrade KC, Tofoli LF, Santos AC, Crippa JAS, Hallak JE, et al. The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. PLoS One. 2015;10(2):e0118143.

pubmed: 25693169 pmcid: 4334486 doi: 10.1371/journal.pone.0118143

Kometer M, Schmidt A, Jäncke L, Vollenweider FX. Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations. J Neurosci. 2013;33(25):10544–51.

pubmed: 23785166 pmcid: 6618596 doi: 10.1523/JNEUROSCI.3007-12.2013

Kraehenmann R. Dreams and psychedelics: neurophenomenological comparison and therapeutic implications. Curr Neuropharmacol. 2017;15(7):1032–42. https://doi.org/10.2174/1573413713666170619092629 .

doi: 10.2174/1573413713666170619092629 pubmed: 28625125 pmcid: 5652011

Downey LA, Sands H, Jones L, Clow A, Evans P, Stalder T, Parrott AC. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits. Hum Psychopharmacol Clin Exp. 2015;30(3):199–207.

doi: 10.1002/hup.2474

Perfect TJ, Stollery B. Memory and metamemory performance in older adults: one deficit or two? Q J Exp Psychol. 1993;46(1):119–35.

doi: 10.1080/14640749308401069

Gärtner M, Weigand A, Scheidegger M, Lehmann M, Wyss PO, Wunder A, et al. Acute effects of ketamine on the pregenual anterior cingulate: linking spontaneous activation, functional connectivity, and glutamate metabolism. Eur Arch Psychiatry Clin Neurosci. 2022;272(4):703–14.

pubmed: 35020021 pmcid: 9095553 doi: 10.1007/s00406-021-01377-2

Lehmann M, Neumann C, Wasserthal S, Schultz J, Delis A, Trautner P, Hurlemann R, Ettinger U. Effects of ketamine on brain function during metacognition of episodic memory. Neurosci Conscious. 2022;2021(1):niaa028. https://doi.org/10.1093/nc/niaa028 .

doi: 10.1093/nc/niaa028

Effinger DP, Quadir SG, Ramage MC, Cone MG, Herman MA. Sex-specific effects of psychedelic drug exposure on central amygdala reactivity and behavioral responding. Transl Psychiatry. 2023;13(1):119.

pubmed: 37031219 pmcid: 10082812 doi: 10.1038/s41398-023-02414-5

Vollenweider FX, Smallridge JW. Classic Psychedelic Drugs: Update on Biological Mechanisms. Pharmacopsychiatry. 2022;55(3):121–38. https://doi.org/10.1055/a-1721-2914 .

doi: 10.1055/a-1721-2914 pubmed: 35079988 pmcid: 9110100

Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX. Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers. Biol Psychiatry. 2015;78(8):572–81.

pubmed: 24882567 doi: 10.1016/j.biopsych.2014.04.010

Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Biol Psychiatry. 2012;72(11):898–906. https://doi.org/10.1016/j.biopsych.2012.04.005 .

doi: 10.1016/j.biopsych.2012.04.005 pubmed: 22578254

Nayak SM, Singh M, Yaden DB, Griffiths RR. Belief changes associated with psychedelic use. J Psychopharmacol. 2023;37(1):80–92.

pubmed: 36317643 doi: 10.1177/02698811221131989

Thiessen MS, Walsh Z, Bird BM, Lafrance A. Psychedelic use and intimate partner violence: The role of emotion regulation. J Psychopharmacol. 2018;32(7):749–55. https://doi.org/10.1177/0269881118771782 .

doi: 10.1177/0269881118771782 pubmed: 29807492

Domínguez-Clavé E, Soler J, Pascual JC, Elices M, Franquesa A, Valle M, et al. Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits. Psychopharmacology. 2019;236:573–80.

pubmed: 30406413 doi: 10.1007/s00213-018-5085-3

Domínguez-Clavé E, Soler J, Elices M, Franquesa A, Álvarez E, Pascual JC. Ayahuasca may help to improve self-compassion and self-criticism capacities. Hum Psychopharmacol Clin Exp. 2022;37(1):e2807.

doi: 10.1002/hup.2807

Sanchez TA, Ramos LR, Araujo F, Schenberg EE, Yonamine M, Lobo I, et al. Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study. J Ethnopharmacol. 2023;320:117430.

doi: 10.1016/j.jep.2023.117430

Agin-Liebes G, Zeifman R, Luoma JB, Garland EL, Campbell WK, Weiss B. Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca. J Psychopharmacol. 2022;36(3):295–308. https://doi.org/10.1177/02698811221080165 .

doi: 10.1177/02698811221080165 pubmed: 35253514 pmcid: 10074827

Abel KM, Allin MP, Kucharska-Pietura K, David A, Andrew C, Williams S, et al. Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. Neuroreport. 2003;14(3):387–91. https://doi.org/10.1097/00001756-200303030-00018 .

doi: 10.1097/00001756-200303030-00018 pubmed: 12634489

Becker B, Steffens M, Zhao Z, Kendrick KM, Neumann C, Weber B, et al. General and emotion-specific neural effects of ketamine during emotional memory formation. Neuroimage. 2017;150:308–17. https://doi.org/10.1016/j.neuroimage.2017.02.049 .

doi: 10.1016/j.neuroimage.2017.02.049 pubmed: 28232170

Murrough JW, Collins KA, Fields J, DeWilde KE, Phillips ML, Mathew SJ, Wong E, Tang CY, Charney DS, Iosifescu DV. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder. Transl Psychiatry. 2015;5(2):e509. https://doi.org/10.1038/tp.2015.10 .

doi: 10.1038/tp.2015.10 pubmed: 25689570 pmcid: 4445748

Monson CM, Wagner AC, Mithoefer AT, Liebman RE, Feduccia AA, Jerome L, et al. MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial. Eur J Psychotraumatol. 2020;11(1):1840123.

pubmed: 33408811 pmcid: 7748057 doi: 10.1080/20008198.2020.1840123

Suddendorf T, Corballis MC. The evolution of foresight: What is mental time travel, and is it unique to humans? Behav Brain Sci. 2007;30(3):299–313. https://doi.org/10.1017/S0140525X07001975 .

doi: 10.1017/S0140525X07001975 pubmed: 17963565

Healy CJ. The acute effects of classic psychedelics on memory in humans. Psychopharmacology. 2021;238:639–53. https://doi.org/10.1007/s00213-020-05756-w .

doi: 10.1007/s00213-020-05756-w pubmed: 33420592

González D, Aixalà MB, Neimeyer RA, Cantillo J, Nicolson D, Farré M. Restorative retelling for processing psychedelic experiences: rationale and case study of complicated grief. Front Psychol. 2022;13:832879. https://doi.org/10.3389/fpsyg.2022.832879 .

doi: 10.3389/fpsyg.2022.832879 pubmed: 35592178 pmcid: 9111738

Grigsby J. Memory Reconsolidation in Psycholytic Psychotherapy. Handbook Med Hallucinogens. 2021;134:143–56.

Speth J, Speth C, Kaelen M, Schloerscheidt AM, Feilding A, Nutt DJ, Carhart-Harris RL. Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide. J Psychopharmacol. 2016;30(4):344–53. https://doi.org/10.1177/0269881116628430 .

doi: 10.1177/0269881116628430 pubmed: 26979587

Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci. 2016;113(17):4853–8. https://doi.org/10.1073/pnas.1518377113 .

doi: 10.1073/pnas.1518377113 pubmed: 27071089 pmcid: 4855588

Singleton SP, Wang JB, Mithoefer M, Hanlon C, Klosinski B, Emerson A, et al. Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder. Front Psych. 2023;13:947622. https://doi.org/10.3389/fpsyt.2022.947622 .

doi: 10.3389/fpsyt.2022.947622

Carhart-Harris RL, Nutt DJ. Serotonin and brain function: a tale of two receptors. J Psychopharmacol. 2017;31(9):1091–120. https://doi.org/10.1177/0269881117725915 .

doi: 10.1177/0269881117725915 pubmed: 28858536 pmcid: 5606297

Artigas F. Serotonin receptors involved in antidepressant effects. Pharmacol Ther. 2013;137(1):119–31. https://doi.org/10.1016/j.pharmthera.2012.09.006 .

doi: 10.1016/j.pharmthera.2012.09.006 pubmed: 23022360

Samuels BA, Anacker C, Hu A, Levinstein MR, Pickenhagen A, Tsetsenis T, et al. 5-HT1A receptors on mature dentate gyrus granule cells are critical for the antidepressant response. Nat Neurosci. 2015;18(11):1606–16. https://doi.org/10.1038/nn.4116 .

doi: 10.1038/nn.4116 pubmed: 26389840 pmcid: 4624493

Boulougouris V, Glennon JC, Robbins TW. Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats. Neuropsychopharmacology. 2008;33:2007–19. https://doi.org/10.1038/sj.npp.1301584 .

doi: 10.1038/sj.npp.1301584 pubmed: 17957219

Frecska E, Móré CE, Vargha A, Luna LE. Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies. J Psychoactive Drugs. 2012;44(3):191–9. https://doi.org/10.1080/02791072.2012.703099 .

doi: 10.1080/02791072.2012.703099 pubmed: 23061318

MacLean KA, Johnson MW, Griffiths RR. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J Psychopharmacol. 2011;25(11):1453–61. https://doi.org/10.1177/0269881111420188 .

doi: 10.1177/0269881111420188 pubmed: 21956378 pmcid: 3537171

McGlothlin W, Cohen S, McGlothlin MS. Long lasting effects of LSD on normals. Arch Gen Psychiatry. 1967;17(5):521–32. https://doi.org/10.1001/archpsyc.1967.01730290009002 .

doi: 10.1001/archpsyc.1967.01730290009002 pubmed: 6054248

Sessa B. Is it time to revisit the role of psychedelic drugs in enhancing human creativity? J Psychopharmacol. 2008;22(8):821–7. https://doi.org/10.1177/0269881108091597 .

doi: 10.1177/0269881108091597 pubmed: 18562421

Janeck AS, Calamari JE, Riemann BC, Heffelfinger SK. Too much thinking about thinking?: metacognitive differences in obsessive–compulsive disorder. J Anxiety Disord. 2003;17(2):181–95. https://doi.org/10.1016/S0887-6185(02)00198-6 .

doi: 10.1016/S0887-6185(02)00198-6 pubmed: 12614661

van Veen V, Carter CS. Error detection, correction, and prevention in the brain: a brief review of data and theories. Clin EEG Neurosci. 2006;37(4):330–5. https://doi.org/10.1177/155005940603700411 .

doi: 10.1177/155005940603700411 pubmed: 17073172

Ho JT, Preller KH, Lenggenhager B. Neuropharmacological modulation of the aberrant bodily self through psychedelics. Neurosci Biobehav Rev. 2020;108:526–41. https://doi.org/10.1016/j.neubiorev.2019.12.006 .

doi: 10.1016/j.neubiorev.2019.12.006 pubmed: 31816361

Zanos P, Gould T. Mechanisms of ketamine action as an antidepressant. Mol Psychiatry. 2018;23(4):801–11. https://doi.org/10.1038/mp.2017.255 .

doi: 10.1038/mp.2017.255 pubmed: 29532791 pmcid: 5999402

Harshaw C. Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression. Psychol Bull. 2015;141(2):311. https://psycnet.apa.org/doi/10.1037/a0038101

pubmed: 25365763 doi: 10.1037/a0038101

Leahy RL, Wupperman P, Edwards E, Shivaji S, Molina N. Metacognition and emotional schemas: Effects on depression and anxiety. Int J Cogn Ther. 2019;12:25–37. https://doi.org/10.1007/s41811-018-0035-8 .

doi: 10.1007/s41811-018-0035-8

Dos Santos RG, Osório FL, Crippa JAS, Riba J, Zuardi AW, Hallak JE. Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Ther Adv Psychopharmacol. 2016;6(3):193–213. https://doi.org/10.1177/2045125316638008 .

doi: 10.1177/2045125316638008 pubmed: 27354908 pmcid: 4910400

Winkelman M. Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca. Curr Drug Abuse Rev. 2014;7(2):101–16. https://doi.org/10.2174/1874473708666150107120011 .

doi: 10.2174/1874473708666150107120011 pubmed: 25563446

Stahl SM. Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate. CNS Spectr. 2018;23(3):187–91. https://doi.org/10.1017/S1092852918001013 .

doi: 10.1017/S1092852918001013 pubmed: 29954475

Vollenweider FX, Geyer MA. A systems model of altered consciousness: integrating natural and drug-induced psychoses. Brain Res Bull. 2001;56(5):495–507. https://doi.org/10.1016/S0361-9230(01)00646-3 .

doi: 10.1016/S0361-9230(01)00646-3 pubmed: 11750795

Forray C, Buller R. Challenges and opportunities for the development of new antipsychotic drugs. Biochem Pharmacol. 2017;143:10–24. https://doi.org/10.1016/j.bcp.2017.05.009 .

doi: 10.1016/j.bcp.2017.05.009 pubmed: 28522405

Marks M. The varieties of psychedelic law. Neuropharmacology. 2023;226:109399.

pubmed: 36565855 doi: 10.1016/j.neuropharm.2022.109399

Belouin SJ, Henningfield JE. Psychedelics: Where we are now, why we got here, what we must do. Neuropharmacology. 2018;142:7–19.

pubmed: 29476779 doi: 10.1016/j.neuropharm.2018.02.018

Dixon Ritchie O, Donley CN, Dixon Ritchie G. From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia. Drug Sci Policy Law. 2023;9:20503245231198472. https://doi.org/10.1177/20503245231198472 .

doi: 10.1177/20503245231198472

Norring, S. A., & Spigarelli, M. G. (2024). The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials. gov. Drug Design, Development and Therapy, 1143-1151.

Siegel JS, Daily JE, Perry DA, Nicol GE. Psychedelic drug legislative reform and legalization in the US. JAMA Psychiatry. 2023;80(1):77–83.

pubmed: 36477830 pmcid: 10069558 doi: 10.1001/jamapsychiatry.2022.4101

Schenberg EE. Psychedelic-assisted psychotherapy: A paradigm shift in psychiatric research and development. Front Pharmacol. 2018;9:323606.

doi: 10.3389/fphar.2018.00733

Greenway KT, Garel N, Jerome L, Feduccia AA. Integrating psychotherapy and psychopharmacology: Psychedelic-assisted psychotherapy and other combined treatments. Expert Rev Clin Pharmacol. 2020;13(6):655–70. https://doi.org/10.1080/17512433.2020.1772054 .

doi: 10.1080/17512433.2020.1772054 pubmed: 32478631

Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

Daniel C Mograbi (DC)

Rafael Rodrigues (R)

Bheatrix Bienemann (B)

Jonathan Huntley (J)

Classifications MeSH